November 2010

CRANBURY, N.J., Nov. 16, 2010 /PRNewswire-FirstCall/ — Palatin Technologies, Inc. (NYSE Amex: PTN) today announced the appointment of Jeffrey D. Edelson, M.D., as Chief Medical Officer. Dr. Edelson has more than 15 years of leadership experience in the successful clinical development of medicines for the pharmaceutical and biotechnology industries.  Dr. Edelson has been responsible for …

Palatin Technologies Appoints Jeffrey D. Edelson, M.D., Chief Medical Officer Read More »

CRANBURY, N.J., Nov. 15, 2010 /PRNewswire-FirstCall/ — Palatin Technologies, Inc. (NYSE Amex: PTN), a biopharmaceutical company dedicated to the development of peptide mimetic and small molecule agonist compounds with a focus on melanocortin and natriuretic peptide receptor systems, today announced results for its first quarter ended September 30, 2010. Palatin reported a net loss of …

Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2011 Results; Teleconference and Webcast to be held on November 16, 2010 Read More »

CRANBURY, N.J., Nov. 12, 2010 /PRNewswire-FirstCall/ — Palatin Technologies, Inc. (NYSE Amex: PTN) will announce its first quarter, fiscal year 2011 financial results on Tuesday, November 16, 2010 before the open of the U.S. financial markets. Palatin will also conduct a conference call and live audio webcast hosted by its executive management team on November …

Palatin Technologies, Inc. to Report Fiscal Year 2011 First Quarter Results; Teleconference and Webcast to be Held on November 16, 2010 Read More »

CRANBURY, N.J., Nov. 2, 2010 /PRNewswire/ — Palatin Technologies, Inc. (NYSE Amex: PTN), announced today that it has received $978,000 in grants under the Patient Protection and Affordable Care Act of 2010 (PPACA), with $847,000 available immediately and $131,000 available no later than 30 days after Palatin’s fiscal year ending June 30, 2011. The grants …

Palatin Technologies, Inc. Receives $978,000 in Grants Under the Patient Protection and Affordable Care Program Read More »